Role of Nrf2 Pathway Activation in Neurological Disorder: A Brief Review. Issue 3 (September 2022)

• Record Type: Journal Article
• Authors: Baba, Mohammad Zubair; Gomathy, S.; Wahedi, Umair
• Is Part Of: Journal of pharmacology and pharmacotherapeutics. Volume 13:Issue 3(2022)
• Page Start: 229
• Page End: 238
• Publication Date: 2022-09
• Subjects: Oxidative stress -- Neurodegeneration -- Nrf2 -- Parkinson's disease -- Antioxidant -- Keap1; 615.1
• DOI: 10.1177/0976500X221128855
• Languages: English
• ISSNs: 0976-500X

Abstract

Oxidative stress plays a crucial role in the emergence of numerous neurodegenerative diseases, with protein accumulation and mitochondrial damage, which result in neurological disorders. To minimize oxidative stress, several defensive mechanisms protect nerve cells by releasing antioxidants such as nuclear erythroid factor2 (Nrf2)-Kelch-like ECH-associated protein1 (Keap1) signaling pathway activation has been proved to be a prospective treatment to reduce oxidative stress and neuroinflammation for protection of neurons in a variety of neurological disorders. In this review, we focus beneficial role of Nrf2 in Alzheimer's and Parkinson's diseases. Nrf2 is proved to be a master regulator of antioxidants by releasing over 250 cytoprotective genes aimed at oxidative stress and neuroinflammation. In animal studies Nrf2 activation is proved to improve autophagy, mitochondrial biogenesis, and Suppression of inflammatory cytokinin which protects neuronal cells and inhibit progressive neurodegeneration.